Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine
Table 3
Optimal vaccine dose performance using overall and individual ratios for J1 together with total vaccine dose ratio when compared to clinical trial dose. Green cells indicate more clinical benefit or a lower total vaccine dose. Red cells indicate less clinical benefit or a higher total vaccine dose.